We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Hospira Teams With Pfenex to Develop Biosimilar of Genentech’s Lucentis
Hospira Teams With Pfenex to Develop Biosimilar of Genentech’s Lucentis
Hospira is looking to add another biosimilar candidate to its growing pipeline by partnering with Pfenex to develop and market a biosimilar of Genentech’s retinal disease therapy Lucentis.